2,5-Dimethoxy-4-sec-butylamphetamine
Psychedelic drug of the phenethylamine class
2,5-Dimethoxy-4-sec-butylamphetamine (DOSB) is a psychedelic drug belonging to the phenethylamine class. It is a structural analog of 2,5-dimethoxy-4-bromoamphetamine (DOB) and is known for its psychoactive effects.
Chemical Structure[edit]

DOSB is a substituted amphetamine, characterized by the presence of methoxy groups at the 2 and 5 positions of the phenyl ring and a sec-butyl group at the 4 position. This structural configuration is responsible for its psychoactive properties.
Pharmacology[edit]
DOSB acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be the primary mechanism underlying its psychedelic effects. The compound's interaction with serotonin receptors leads to alterations in perception, mood, and cognition.
Effects[edit]
The effects of DOSB are similar to those of other psychedelic phenethylamines, such as 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-methylamphetamine (DOM). Users report visual and auditory hallucinations, altered thought processes, and changes in time perception. The intensity and duration of these effects can vary based on dosage and individual sensitivity.
Synthesis[edit]
The synthesis of DOSB involves the alkylation of 2,5-dimethoxyphenethylamine with sec-butyl halides. This process requires careful control of reaction conditions to ensure the correct substitution pattern on the phenyl ring.
Legal Status[edit]
The legal status of DOSB varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to other regulated psychedelics. Users should be aware of the legal implications of possessing or distributing DOSB in their region.
Related Compounds[edit]

DOSB is part of a family of compounds known as the "DOx" series, which includes other psychedelics such as DOI, DOB, and DOM. These compounds share a common phenethylamine backbone with various substitutions that influence their pharmacological profiles and effects.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian